epi-2021-0230 Suppl. Material

Supplementary Table 1. Overall sample information and patients’ characteristics.Supplementary Table 2. Primer sequences for qRT-PCRSupplementary Table 3. Four miRNAs expression level of UC patients and HCs in miRNA sequencing dataSupplementary Figure 1 Correlation analysis of test samples. (A) CircRNAs data correlation analysis of test samples. (B) MiRNAs data correlation analysis of test samples. (C) MRNAs data correlation analysis of test samples.Supplementary Figure 2 Comparative analysis of hsa_circ_0001021 from UC patients treated with or without medicine. (A) Comparative analysis of hsa_circ_0001021 from UC patients treated with or without 5-ASA. (B) Comparative analysis of hsa_circ_0001021 from UC patients treated with or without steroids. NS, nonsignificant.